<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="16764">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02068209</url>
  </required_header>
  <id_info>
    <org_study_id>Gany-123</org_study_id>
    <nct_id>NCT02068209</nct_id>
  </id_info>
  <brief_title>Evaluation of the Role of Tramadol 50mg as an Analgesic During Outpatient Hysteroscopy</brief_title>
  <official_title>Evaluation of the Role of Tramadol 50mg as an Analgesic During Outpatient Hysteroscopy: A Double Blinded Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <authority>Egypt: Ministry of Higher Education</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the role of Tramadol 50mg in reducing pain during
      outpatient hysteroscopy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a prospective double blinded randomised controlled trial. 100 women will be
      recruited from the office hysteroscopy clinic in Cairo university hospitals.

      All patients attending the outpatient hysteroscopy clinic will be invited to participate in
      the study. The invitation will include a clear full explanation of the study and patients
      will provide written consents. Only patients consenting to participate will be included in
      the trial.

      Tramadol and placebo will be enclosed in sealed envelopes which will be numbered using a
      computer generated random table. Neither the patient nor the physician will be aware of the
      drug used. Patients will be categorized into 2 groups: Group I who will receive Tramadol
      50mg (Tramadol, October Pharma, Giza, Egypt) 1 hour before the procedure, group II who will
      received a placebo acting as the control group.

      Full history will be taken followed by general and local examination. The procedure will be
      done in the lithotomy position. Hysteroscopy will be done using a 5mm outer diameter
      continuous flow hysteroscope with a French working channel and a 30 degrees direction of
      view provided by Techno GmbH and CO. The hysteroscope will be introduced using the
      vaginoscopy technique, in which no speculum will be used. The cervix will be detected and
      the external os will be identified using the hysteroscope. The hysteroscope will be
      introduced in the uterine cavity. Saline will be used as the distension medium and the
      pressure will be set at 100mm Hg. The anterior wall, posterior wall and tubal ostea will be
      visualized, any polyps, adhesions septa, congenital malformations or submucous fibroids will
      be noted.

      Base line characteristics will be compared and the main outcome measure will be patients'
      pain perception during the procedure and 30 minutes later, this will be determined using a
      visual analogue scale.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Pain perceived by the patient during the procedure</measure>
    <time_frame>10 minutes after starting the procedure.</time_frame>
    <safety_issue>No</safety_issue>
    <description>Pain will be assessed by a visual analogue scale 10 minutes after starting the procedure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain perceived by the patient 30 minutes after the procedure.</measure>
    <time_frame>30 minutes after the procedure.</time_frame>
    <safety_issue>No</safety_issue>
    <description>The level of pain will be assessed 30 minutes after the procedure by a visual analogue scale.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Tramadol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive Tramadol 50mg 1 hour before outpatient hysteroscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will receive a placebo 1 hour before the procedure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tramadol</intervention_name>
    <description>patients will receive Tramadol 50mg orally 1 hour before outpatient hysteroscopy.</description>
    <arm_group_label>Tramadol</arm_group_label>
    <other_name>Tramadol 50mg</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>patients will receive a placebo 1 hour before outpatient hysteroscopy</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients referred for outpatient hysteroscopy

          -  Consent to the procedure

        Exclusion Criteria:

          -  Premenstrual patients

          -  Known cardiac disease

          -  Known allergy to Tramadol
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>AbdelGany MA Hassan, MRCOG, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>AbdelGany MA Hassan, MRCOG, MD</last_name>
    <phone>00201017801604</phone>
    <email>abdelgany2@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hisham M Haggag, MD</last_name>
    <phone>0020122 4460 134</phone>
    <email>hmhaggag@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cairo University Hospitals</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>AbdelGany MA Hassan, MRCOG, MD</last_name>
      <phone>00217801604</phone>
      <email>abdelgany2@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Hisham M Haggag, MD</last_name>
      <phone>0020122 4460 134</phone>
      <email>hmhaggag@hotmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>AbdelGany MA Hassan, MRCOG, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hisham M Haggag, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Floris S, Piras B, Orr√π M, Silvetti E, Tusconi A, Melis F, Tuveri M, Piga M, Paoletti AM, Melis GB. Efficacy of intravenous tramadol treatment for reducing pain during office diagnostic hysteroscopy. Fertil Steril. 2007 Jan;87(1):147-51. Epub 2006 Nov 1.</citation>
    <PMID>17081540</PMID>
  </reference>
  <reference>
    <citation>Sharma JB, Aruna J, Kumar P, Roy KK, Malhotra N, Kumar S. Comparison of efficacy of oral drotaverine plus mefenamic acid with paracervical block and with intravenous sedation for pain relief during hysteroscopy and endometrial biopsy. Indian J Med Sci. 2009 Jun;63(6):244-52. doi: 10.4103/0019-5359.53394.</citation>
    <PMID>19602758</PMID>
  </reference>
  <reference>
    <citation>van Dongen H, de Kroon CD, Jacobi CE, Trimbos JB, Jansen FW. Diagnostic hysteroscopy in abnormal uterine bleeding: a systematic review and meta-analysis. BJOG. 2007 Jun;114(6):664-75. Review.</citation>
    <PMID>17516956</PMID>
  </reference>
  <reference>
    <citation>O'Flynn H, Murphy LL, Ahmad G, Watson AJ. Pain relief in outpatient hysteroscopy: a survey of current UK clinical practice. Eur J Obstet Gynecol Reprod Biol. 2011 Jan;154(1):9-15. doi: 10.1016/j.ejogrb.2010.08.015. Review.</citation>
    <PMID>20926175</PMID>
  </reference>
  <reference>
    <citation>Modi H, Mazumdar B, Bhatt J. Study of interaction of tramadol with amlodipine in mice. Indian J Pharmacol. 2013 Jan-Feb;45(1):76-9. doi: 10.4103/0253-7613.106440.</citation>
    <PMID>23543914</PMID>
  </reference>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 5, 2014</lastchanged_date>
  <firstreceived_date>February 16, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>AbdelGany Hassan</investigator_full_name>
    <investigator_title>Dr Hassan</investigator_title>
  </responsible_party>
  <keyword>Outpatient hysteroscopy</keyword>
  <keyword>Tramadol</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Analgesics</mesh_term>
    <mesh_term>Tramadol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
